Travere Therapeutics granted inducement equity covering 178,580 shares to 33 new employees, including stock options and RSUs, under Nasdaq Listing Rule 5635(c)(4).
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
